Prelude Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-19,101
| Closed | -$907K | – | 1272 |
|
|
2025
Q3 | $907K | Buy |
19,101
+29
| +0.2% | +$1.4K | 0.07% | 330 |
|
|
2025
Q2 | $1.02M | Sell |
19,072
-4,918
| -21% | -$223K | 0.1% | 256 |
|
|
2025
Q1 | $971K | Buy |
23,990
+6,118
| +34% | +$259K | 0.1% | 314 |
|
|
2024
Q4 | $497K | Buy |
17,872
+1,572
| +10% | +$47.6K | 0.04% | 594 |
|
|
2024
Q3 | $468K | Buy |
+16,300
| New | +$425K | 0.04% | 658 |
|
|
2023
Q4 | – | Sell |
-11,243
| Closed | -$569K | – | 1112 |
|
|
2023
Q3 | $569K | Buy |
+11,243
| New | +$523K | 0.05% | 431 |
|
